These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3208098)

  • 1. Decrease of rapid-eye-movement sleep in the light by intraventricular application of a VIP-antagonist in the rat.
    Mirmiran M; Kruisbrink J; Bos NP; Van der Werf D; Boer GJ
    Brain Res; 1988 Aug; 458(1):192-4. PubMed ID: 3208098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP.
    Bredow S; Kacsóh B; Obál F; Fang J; Krueger JM
    Brain Res; 1994 Oct; 660(2):301-8. PubMed ID: 7820699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat.
    Weick RF; Stobie KM; Noh KA
    Neuroendocrinology; 1992 Nov; 56(5):646-52. PubMed ID: 1488097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intracoronary infusion of the vasoactive intestinal peptide antagonist [4Cl-D-Phe6-Leu17]VIP in the awake dog.
    Quebbemann BB; Rivier J; Bache RJ
    Peptides; 1991; 12(5):989-93. PubMed ID: 1800959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain.
    Itoh S; Katsuura G; Takashima A
    Peptides; 1988; 9(2):315-7. PubMed ID: 3375138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.
    Pandol SJ; Dharmsathaphorn K; Schoeffield MS; Vale W; Rivier J
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G553-7. PubMed ID: 2421587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
    Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
    Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats.
    Fang J; Payne L; Krueger JM
    Brain Res; 1995 Jul; 686(1):23-8. PubMed ID: 7583267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide (VIP) and cerebrospinal fluid (CSF) of sleep-deprived cats restores REM sleep in insomniac recipients.
    Prospéro-Garcia O; Morales M; Arankowsky-Sandoval G; Drucker-Colin R
    Brain Res; 1986 Oct; 385(1):169-73. PubMed ID: 2945620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased REM sleep and altered circadian sleep regulation in mice lacking vasoactive intestinal polypeptide.
    Hu WP; Li JD; Colwell CS; Zhou QY
    Sleep; 2011 Jan; 34(1):49-56. PubMed ID: 21203371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal polypeptide excites medial pontine reticular formation neurons in the brainstem rapid eye movement sleep-induction zone.
    Kohlmeier KA; Reiner PB
    J Neurosci; 1999 May; 19(10):4073-81. PubMed ID: 10234035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid (CSF) extracted immediately after REM sleep deprivation prevents REM rebound and contains vasoactive intestinal peptide (VIP).
    Jiménez-Anguiano A; Báez-Saldaña A; Drucker-Colín R
    Brain Res; 1993 Dec; 631(2):345-8. PubMed ID: 8131065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in the rat.
    Kruisbrink J; Mirmiran M; Van der Woude TP; Boer GJ
    Brain Res; 1987 Sep; 419(1-2):76-86. PubMed ID: 3676743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide microinjections into the oral pontine tegmentum enhance rapid eye movement sleep in the rat.
    Bourgin P; Lebrand C; Escourrou P; Gaultier C; Franc B; Hamon M; Adrien J
    Neuroscience; 1997 Mar; 77(2):351-60. PubMed ID: 9472395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide promotes sleep without effects on brain temperature in rats at night.
    Obál F; Sáry G; Alföldi P; Rubicsek G; Obál F
    Neurosci Lett; 1986 Feb; 64(2):236-40. PubMed ID: 3960403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is vasoactive intestinal polypeptide (VIP) a sleep factor?
    Drucker-Colín R; Bernal-Pedraza J; Fernández-Cancino F; Oksenberg A
    Peptides; 1984; 5(4):837-40. PubMed ID: 6494029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits.
    Obal F; Opp M; Cady AB; Johannsen L; Krueger JM
    Brain Res; 1989 Jun; 490(2):292-300. PubMed ID: 2765864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.
    Murck H; Guldner J; Colla-Müller M; Frieboes RM; Schier T; Wiedemann K; Holsboer F; Steiger A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R905-11. PubMed ID: 8897980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypnogenic properties of the vasoactive intestinal polypeptide in rats].
    Riou F; Cespuglio R; Jouvet M
    C R Seances Acad Sci III; 1981 Nov; 293(12):679-82. PubMed ID: 6460548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of VIP and atropine induces REM sleep in cats rendered insomniac by PCPA.
    Prospero-García O; Jiménez-Anguiano A; Drucker-Colín R
    Neuropsychopharmacology; 1993 Jun; 8(4):387-90. PubMed ID: 8512625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.